IL81889A0 - Assay of inhibin - Google Patents

Assay of inhibin

Info

Publication number
IL81889A0
IL81889A0 IL81889A IL8188987A IL81889A0 IL 81889 A0 IL81889 A0 IL 81889A0 IL 81889 A IL81889 A IL 81889A IL 8188987 A IL8188987 A IL 8188987A IL 81889 A0 IL81889 A0 IL 81889A0
Authority
IL
Israel
Prior art keywords
inhibin
assay
Prior art date
Application number
IL81889A
Other languages
English (en)
Original Assignee
Biotech Australia Pty Ltd
Univ Monash
St Vincents Inst Med Res
Prince Henrys Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotech Australia Pty Ltd, Univ Monash, St Vincents Inst Med Res, Prince Henrys Hospital filed Critical Biotech Australia Pty Ltd
Publication of IL81889A0 publication Critical patent/IL81889A0/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
IL81889A 1986-03-13 1987-03-13 Assay of inhibin IL81889A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPH501986 1986-03-13

Publications (1)

Publication Number Publication Date
IL81889A0 true IL81889A0 (en) 1987-10-20

Family

ID=3771514

Family Applications (1)

Application Number Title Priority Date Filing Date
IL81889A IL81889A0 (en) 1986-03-13 1987-03-13 Assay of inhibin

Country Status (8)

Country Link
EP (1) EP0260306A4 (ja)
JP (1) JPS63503086A (ja)
AU (1) AU599373B2 (ja)
CA (1) CA1307736C (ja)
IL (1) IL81889A0 (ja)
NZ (1) NZ219609A (ja)
WO (1) WO1987005702A1 (ja)
ZA (1) ZA871844B (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5942220A (en) * 1990-03-16 1999-08-24 Chiron Corporation Inhibitor of cytokine activity and applications thereof
GB9224965D0 (en) * 1992-11-28 1993-01-20 Kodak Ltd Antenatal screening for chromosomal abnormalities
GB9316369D0 (en) * 1993-08-06 1993-09-22 Surface Active Ltd Diagnostic method
GB9410345D0 (en) * 1994-05-24 1994-07-13 Univ Oxford Brookes Method of genetic testing
GB9606261D0 (en) * 1996-03-25 1996-05-29 Johnson & Johnson Clin Diag Prenatal screening for fetal abnormalities
GB9614615D0 (en) * 1996-07-11 1996-09-04 Isis Innovation Diagnosis of pre-eclampsia
US6620590B2 (en) 1996-07-11 2003-09-16 Isis Innovation Limited Diagnosis of pre-eclampsia
WO2000050638A1 (en) 1999-02-25 2000-08-31 Auckland Uniservices Limited Diagnosis and therapy of premature ovarian failure
US9221867B2 (en) 2003-01-06 2015-12-29 Angiochem Inc. Method for transporting a compound across the blood-brain barrier
AU2004223796A1 (en) * 2003-03-28 2004-10-07 Monash University Diagnosis of advanced cancer
JP5175108B2 (ja) 2005-02-18 2013-04-03 アンジオケム・インコーポレーテッド 血液脳関門を介して化合物を輸送するためのアプロチニンポリペプチド
EP2233156B1 (en) 2005-07-15 2013-05-01 Angiochem Inc. Use of aprotinin polypeptides as carriers in pharmaceutical conjugates
US9365634B2 (en) 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
AU2009304560A1 (en) 2008-10-15 2010-04-22 Angiochem Inc. Conjugates of GLP-1 agonists and uses thereof
CA2745524C (en) 2008-12-05 2020-06-09 Angiochem Inc. Conjugates of neurotensin or neurotensin analogs and uses thereof
US8853353B2 (en) 2008-12-17 2014-10-07 Angiochem, Inc. Membrane type-1 matrix metalloprotein inhibitors and uses thereof
AU2010239069B2 (en) 2009-04-20 2015-05-14 Angiochem Inc Treatment of ovarian cancer using an anticancer agent conjugated to an Angiopep-2 analog
EP2448965A4 (en) 2009-07-02 2015-02-11 Angiochem Inc MULTIMEPEPTID CONJUGATES AND ITS USES
CN107921143B (zh) 2015-06-15 2021-11-19 安吉奥开米公司 用于治疗软脑膜癌病的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341617C (en) * 1984-06-08 2011-06-28 Henry George Burger Inhibin isolated from ovarian follicular fluid
WO1986006076A1 (en) * 1985-04-18 1986-10-23 Biotechnology Australia Pty. Ltd. Recombinant inhibin
US4624944A (en) * 1985-06-14 1986-11-25 The Regents Of The University Of California Human seminal alpha-inhibins
US4740587A (en) * 1985-07-18 1988-04-26 The Salk Institute For Biological Studies Inhibin and method of purifying same
NZ217727A (en) * 1985-10-03 1990-05-28 Genentech Inc Nucleic acid encoding alpha or b chain of inhibin, its production and compositions containing it

Also Published As

Publication number Publication date
CA1307736C (en) 1992-09-22
WO1987005702A1 (en) 1987-09-24
NZ219609A (en) 1990-09-26
EP0260306A1 (en) 1988-03-23
AU7203687A (en) 1987-10-09
ZA871844B (en) 1988-05-25
AU599373B2 (en) 1990-07-19
EP0260306A4 (en) 1990-09-26
JPS63503086A (ja) 1988-11-10

Similar Documents

Publication Publication Date Title
EP0155193A3 (en) Methods of assay
IL81889A0 (en) Assay of inhibin
ZA895648B (en) Method of assay
GB8701687D0 (en) Assay technique
ZA874173B (en) Methods of immunoassay
GB8611205D0 (en) Determination of antigen
GB2197470B (en) Endotoxin assay
ZA893927B (en) Method of assay
GB8727479D0 (en) Riboflavin-linked assay
GB8621495D0 (en) Assay
ZA851654B (en) Methods of assay
GB8717863D0 (en) Determination of antibodies
GB8610629D0 (en) Assay
GB8604708D0 (en) Assay
GB8607264D0 (en) Assay
GB8605849D0 (en) Free analyte assay
GB8619113D0 (en) Assay techniques
IL110557A0 (en) Electrochemiluminescent assay
IL119895A0 (en) Electrochemiluminescent assay
GB8501925D0 (en) Methods of assay
GB8417538D0 (en) Methods of assay
GB8624892D0 (en) Assay method
GB8624891D0 (en) Assay method
GB8713418D0 (en) Assay
GB8719631D0 (en) Assay